Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Pharmas See Big Advantage In Moving Acquisitions To India

This article was originally published in PharmAsia News

Executive Summary

Indian drug makers that made U.S. and European acquisitions have discovered they can save as much as 40 percent in manufacturing costs by moving production to India. Piramal Healthcare became an example of that success when it moved the inhalation anesthetics acquired from Rhodia of the United Kingdom to its manufacturing facilities in India. The success has led Piramal to consider moving the products of its U.S. acquisition, Minrad International, to India. Dr. Reddy's is considering a similar production shift. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts